A Multifunctional Hydrogel Integrating Hemostatic, Antioxidant, and Antibacterial Properties for Infected and Diabetic Wound Regeneration
Source abstract
Abstract
Wound management, especially for infected and diabetic ulcers, poses a persistent clinical challenge, largely attributed to sustained inflammation, bacterial colonization, and compromised tissue regeneration. Herein, a multifunctional hydrogel (CBOS) with integrated therapeutic properties was developed through Schiff base reaction between betaine-modified chitosan (CSBT) and oxidized sodium alginate (OSA), with poly(vinyl alcohol) and sodium borate incorporated to enhance network stability. The resulting CBOS hydrogel exhibited a uniform porous microstructure, robust viscoelasticity, high swelling capacity, and appropriate water vapor transmission. Comprehensive biocompatibility assessments confirmed its negligible cytotoxicity and applicable hemocompatibility. The hydrogel demonstrated broad-spectrum tissue adhesion and potent hemostatic efficacy in murine tail incision and liver hemorrhage models. Moreover, CBOS displayed antioxidant activity by scavenging multiple free radicals and reducing intracellular reactive oxygen species in H 2 O 2 -stressed fibroblasts. Antibacterial evaluations revealed potent activity against S. aureus, with molecular docking studies suggesting multitarget interactions with key bacterial proteins, including AgrA, ClpP, and FtsZ. In vitro, CBOS significantly enhances fibroblast migration. In vivo, the hydrogel accelerated healing in both S. aureus -infected full-thickness wounds and diabetic chronic wounds, as evidenced by reduced bacterial burden, attenuated inflammatory responses, enhanced collagen deposition, and promoted neovascularization. With its integrated hemostatic, antioxidant, antibacterial, and pro-regenerative properties, the CBOS hydrogel offers a viable and attractive therapeutic approach for complex wound tissue repair.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Hemostasis and retained surgical items · Surgical Sutures and Adhesives
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmacy
Henan Medical University
Experimental Teaching Center of Biology and Basic Medicine
North Henan Medical University
School of Pharmacy
Xinxiang University
Funding
Natural Science Foundation of Henan Province · Key Research and Development Program of Henan · Henan Provincial College Students? Innovation and Entrepreneurship Training Program · Key Project for Institutions of Higher Education in Henan Province
References (44)
Show source-provided references
1. 10.1021/acs.nanolett.5c0427010.1021/acs.nanolett.5c04270 ↗
2. 10.1016/j.bioactmat.2024.08.03610.1016/j.bioactmat.2024.08.036 ↗
3. 10.1016/j.mtbio.2023.10081010.1016/j.mtbio.2023.100810 ↗
4. 10.1002/adfm.20190554410.1002/adfm.201905544 ↗
5. 10.1016/j.bioactmat.2023.03.00510.1016/j.bioactmat.2023.03.005 ↗
6. 10.1186/1472-6890-14-2010.1186/1472-6890-14-20 ↗
7. 10.1093/burnst/tkae08410.1093/burnst/tkae084 ↗
8. 10.1016/j.ijbiomac.2024.13666910.1016/j.ijbiomac.2024.136669 ↗
9. 10.1021/acs.nanolett.3c0243410.1021/acs.nanolett.3c02434 ↗
10. 10.1016/j.bioactmat.2025.07.02610.1016/j.bioactmat.2025.07.026 ↗
11. 10.1016/j.biomaterials.2025.12313410.1016/j.biomaterials.2025.123134 ↗
12. 10.1016/j.colsurfb.2025.11468310.1016/j.colsurfb.2025.114683 ↗
13. 10.1002/adhm.20250143010.1002/adhm.202501430 ↗
14. 10.1038/s41467-025-58987-w10.1038/s41467-025-58987-w ↗
15. 10.1002/advs.20230615210.1002/advs.202306152 ↗
16. 10.1016/j.colsurfb.2026.11555310.1016/j.colsurfb.2026.115553 ↗
17. 10.1016/j.mtbio.2022.10043110.1016/j.mtbio.2022.100431 ↗
18. 10.1016/j.bioactmat.2021.12.01210.1016/j.bioactmat.2021.12.012 ↗
19. 10.1016/j.bioactmat.2024.04.01110.1016/j.bioactmat.2024.04.011 ↗
20. 10.1016/j.carbpol.2024.12303310.1016/j.carbpol.2024.123033 ↗
21. 10.1021/acsnano.3c0862510.1021/acsnano.3c08625 ↗
22. 10.1016/j.colsurfb.2023.11369710.1016/j.colsurfb.2023.113697 ↗
23. 10.1016/j.colsurfb.2024.11416010.1016/j.colsurfb.2024.114160 ↗
24. 10.1016/j.colsurfb.2024.11434610.1016/j.colsurfb.2024.114346 ↗
25. 10.1016/j.ijbiomac.2025.14080110.1016/j.ijbiomac.2025.140801 ↗
26. 10.1021/acsami.8b1006410.1021/acsami.8b10064 ↗
27. 10.1016/j.ijpharm.2024.12442110.1016/j.ijpharm.2024.124421 ↗
28. 10.1016/j.ijbiomac.2024.13517710.1016/j.ijbiomac.2024.135177 ↗
29. 10.1021/acsami.4c1633310.1021/acsami.4c16333 ↗
30. 10.1016/j.ijbiomac.2025.14628010.1016/j.ijbiomac.2025.146280 ↗
31. 10.1021/acsami.5c0728810.1021/acsami.5c07288 ↗
32. 10.1016/j.colsurfb.2025.11539110.1016/j.colsurfb.2025.115391 ↗
33. 10.1016/j.cbi.2023.11071010.1016/j.cbi.2023.110710 ↗
34. 10.1016/j.ijbiomac.2024.13893010.1016/j.ijbiomac.2024.138930 ↗
35. 10.1186/s12951-025-03393-z10.1186/s12951-025-03393-z ↗
36. 10.1016/j.mtbio.2025.10187010.1016/j.mtbio.2025.101870 ↗
37. 10.1016/j.ntm.2025.10007010.1016/j.ntm.2025.100070 ↗
38. 10.1016/j.ntm.2024.10003510.1016/j.ntm.2024.100035 ↗
39. 10.1021/acsomega.1c0717810.1021/acsomega.1c07178 ↗
40. 10.1016/j.bcp.2023.11581410.1016/j.bcp.2023.115814 ↗
41. 10.1021/acs.jnatprod.2c0013810.1021/acs.jnatprod.2c00138 ↗
42. 10.1016/j.actbio.2015.01.00510.1016/j.actbio.2015.01.005 ↗
43. 10.3389/fbioe.2022.96500610.3389/fbioe.2022.965006 ↗
44. 10.1039/D3RA00300K10.1039/D3RA00300K ↗